SCHEMBL17173129

SCHEMBL17173129

CC(C)[C@@H]1CN(C(=O)OC(C)(C)C)C[C@@H]1F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR1H2 P55055 1/20 0.45
▸ USP30 Q70CQ3 2/20 0.43
▸ HPGD P15428 1/20 0.41
▸ USP2 O75604 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ RECQL P46063 1/20 0.39
▸ RORC P51449 1/20 0.38
▸ KDM4E B2RXH2 2/20 0.37
▸ MAPT P10636 3/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ DPP4 P27487 1/20 0.36
▸ EPHX1 P07099 1/20 0.36
▸ THRB P10828 1/20 0.36
▸ DDB1 Q16531 1/20 0.36
▸ CRBN Q96SW2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17173130 1.00 NR1H2 (0.45) NR1H2USP30HPGDUSP2SMN1; SMN2
SCHEMBL26791061 0.86 HPGD (0.44) USP30HPGDUSP2SMN1; SMN2RECQL
SCHEMBL25010445 0.83 NR1H2 (0.47) NR1H2USP30HPGDUSP2SMN1; SMN2
SCHEMBL16224550 0.80 NR1H2 (0.50) NR1H2USP30HPGDUSP2SMN1; SMN2
SCHEMBL15742218 0.80 NR1H2 (0.50) NR1H2USP30HPGDUSP2SMN1; SMN2
SCHEMBL31618826 0.80 NR1H2 (0.50) NR1H2USP30HPGDUSP2SMN1; SMN2
SCHEMBL15749475 0.80 NR1H2 (0.50) NR1H2USP30HPGDUSP2SMN1; SMN2
SCHEMBL17438450 0.80 NR1H2 (0.50) NR1H2USP30HPGDUSP2SMN1; SMN2
SCHEMBL16727831 0.80 NR1H2 (0.50) NR1H2USP30HPGDUSP2SMN1; SMN2
SCHEMBL17510289 0.80 NR1H2 (0.50) NR1H2USP30HPGDUSP2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9260439-B2 Dihydropyrrolopyrimidine derivatives PFIZER INC. (US) 2016-02-16 — — US disclosed
US-9260439-B2 Dihydropyrrolopyrimidine derivatives PFIZER INC. (US) 2016-02-16 — — US disclosed
US-20150291604-A1 DIHYDROPYRROLOPYRIMIDINE DERIVATIVES PFIZER (US) 2015-10-15 — — US disclosed
US-20150291604-A1 DIHYDROPYRROLOPYRIMIDINE DERIVATIVES PFIZER (US) 2015-10-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150291604-A1 DIHYDROPYRROLOPYRIMIDINE DERIVATIVES DPYD, TPD52L2, DTYMK NR1H2 3017/4885USP30 3434/4885HPGD 543/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback